Introduction
(+)-Dicentrine, a n a porphine alkaloid p resent abundantly in a va riety of genera in the plant families Lauraceae (Chen et al., 1991) , Papaveraceae (Lalezari et al ., 1976) , Menispermaceae (D e W et et a l., 2 007), a nd F umariaceae (I srailov et al ., 1984) , w as demonstrated t o b e a s elective α 1 -adrenoceptor a ntagonist ( Teng e t al., 1991) and to possess potent biological ac tivities, i ncluding an tiarrhythmic (Su et al ., 1 994),
anti-platelet aggregation (Teng et al., 1991; Yu et al., 1992a) , antihypertensive (Yu et al., 1992b ), a nti-hyperlipidaemic ( Yu et a l., 1 993), a nd a ntitumor ( Stévigny et a l., 2005 ) activities. The antiarrhythmic effect of dicentrine has been shown in the rabbit (Young et al., 1994) and dog (Chang et al., 1995) models. These results showed dicentrine to be a promising drug candidate as a class I and class III antiarrhythmic agent. Another study revealed that dicentrine c ould r elieve bl adder outlet o bstruction c aused by be nign prostatic hyperplasia. (Yu et al., 1994) . Oral administration of dicentrine (5 mg kg -1 ) to conscious spontaneously hypertensive r ats r esulted in a significant r eduction in m ean arterial pressure, which was observed 1 h after administration and the hypotensive effect persisted for over 15 h (Yu et al., 1992b) . This long-acting phenomenon indicated that dicentrine had either long half-life or active metabolites. One pharmacokinetic study of dicentrine (10 mg kg -1 , i.v.) in rat (Tsai et al., 1996) revealed that the dis tribution and commonly a nalyzed b y LC-MS/MS. The i nformation provided by s uch technique, however, is usually not enough to determine the exact structure. Up to now, NMR and HPLC are recognized generally as the most powerful tools for structure elucidation and analytic s cale separation, re spectively. H ence the HPLC-NMR t echnique has been applied to study the metabolic profile of some drugs (Burton et al., 1997; Spraul et al., 2003) . The HPLC-SPE-NMR technique h as also b een s uccessfully applied in n atural products analysis (Wang and Lee, 2005; Lam et al., 2007; Lee et al., 2007) The following describes the outcome of our effort on this aspect.
This article has not been copyedited and formatted. The final version may differ from this version. Lab Animal. Two mature (6 months old) female Langyu small-ear miniature pigs were br ed a t T aitung Breeding Ani mal Propagation, T aiwan Livestock Research Institute, Taitung, Taiwan, a nd were tr ansported to N TU V eterinary H ospital f or th e experiment. Th ey we re housed in a s heltered outdoor fenced space with good ventilation, a nd allowed f orage and water ad li bitum th roughout th e e xperiment. The animal experiment was conducted according to a protocol approved by the Institutional Animal C are a nd Use Committee (IACUC), National T aiwan U niversity (NTU),
Approval No. 95 (073).
This article has not been copyedited and formatted. The final version may differ from this version. mg di centrine/kg) through a soft pla stic gastric t ube. Then the p igs we re kept in metabolic c ages equipped wi th n ormal f odder a nd wa ter. The urine a nd f eces we re collected separately and were stored at 4ºC before further processing.
Urine Collection a nd P retreatment Procedures. The u rine of t he first p ig w as collected ove r a 0-to 24 -h pe riod to give ca 500 mL which was passed th rough a n Feces C ollection a nd P retreatment Procedures. The feces s amples were collected over a 0-to 48-h period. They were suspended in 90% MeOH (aq) (5 mL) in a 15-mL centrifuge tube , vortexed a nd c entrifuged f or 1 0 min at 3000 r pm. The supernatant w as collected. T his procedure w as r epeated three times. T he combined supernatants were evaporated under reduced pressure at 40ºC to yield a residue (560 mg, 
HPLC-SPE-NMR. HPLC-DAD-SPE-NMR (400 MHz) w as carried out using an
Agilent 1100 liquid chromatograph (Waldbronn, Germany) equipped with a photodiode array detector (Bruker DAD, Bruker, Rheinstetten, Germany), followed by a Prospekt 2 automated solid-phase extraction unit (Spark Holland, Emmen, Holland), containing 96
HySphere-Resin GP cartridges (10 × 2 mm, 10-12 μ m), w hich connected t o a 30 μ Linverse NMR probe equipped i n a Bru ker A vance 400 N MR s pectrometer. T he metabolites with similar UV absorption to d icentrine ( λ max 2 80 a nd 310 nm) we re identified by HPLC-DAD analysis and were trapped individually by resin GP cartridge.
Through the procedure described in our previous study (Lee et al., 2007) , the and NMe (δ 3.57 vs. (Fig. 4) .
Results

HPLC a nalysis of t he p hase I me tabolites ( MI-1~MI-9).
HPLC-SPE-NMR analysis (MII-3~4) and semi-Prep. RP-HPLC separation of the phase II metabolites ( MII-1~2 an d MII-5~15). Following t he HPLC an alytical
conditions for MII-1~15, HPLC-SPE-NMR was performed. The on-line NMR spectra of these compounds were shown in Figs S2 and S3. In order to confirm the structures of these more sophisticated phase II conjugated metabolites by more extensive 1D and 2D
NMR da ta, m ost ph ase I I metabolites ( MII-1~2, MII-5~15) w ere i solated via semi-preparative RP-HPLC, using the delivery system MeCN− 0.1%TFA.
Structure el ucidation o f th e ph ase II m etabolites ( MII-1~15). The m olecular
formulas o f MII-1~15 are shown in Table 4 , a s deduced f rom HR ESIMS. F rom the MS 2 an d MS 3 data, MII-3~15 we re i dentified a s m onoglucuronide c onjugates, while MII-1 was a diglucuronide and MII-2 was conjugated with one glucuronic acid and one glucose unit (Table 4) NMR signals, an AB or AX system around δ 6.00 (Table 2 and S2). Tables S2, S20 Accordingly, MII-3 is reasonably el ucidated as phanostenine 10-O-β-D-glucuronide, a structural isomer of MII-14 with exchanged C-9 and C-10 substitutions. et al., 1975) . The NOESY spectrum of MII-11 showed the correlation of H -8/ 9-OMe and H -11/ 10-OMe. T he H MBC spectrum (Fig. S 24) showed t he correlation of C-3 ( δ 137 .6, s)/ GlcUA H-1 (δ 5. 31, d, J = 7. 6 Hz) a nd H-4 ( δ 5.24).
9-O-Glucuronides (MII-9~10 and -14 ~15).
Metabolites c ontaining 3-glucuronyloxy group ( MII-11~13
These structural information incorporated with the MS data, thus, established MII-11 as 3-β-D-glucuronyloxy-4R-hydroxynordicentrine. MII-12 h ad t he m olecular formula C 26 H 29 NO 11 , as deduced f rom HR ESIMS, wi th one oxyge n le ss than MII-11. T he 1 H NMR spectrum of MII-12.TFA (Table S2 ) was similar to that of MII-11.TFA (Table 2) (Fig. S28) . Thus, MII-13 was established as 3-β-D-glucuronyloxydicentrine.
Metabolites retaining 9, 10-dimethoxy g roups ( MII-4~8). Metabolites MII-4~8
are 1 ,2-O,O-demethylenated monoglucuronides as i ndicated by the 1 H N MR spectra, lacking the -OCH 2 O-signals but retaining two methoxy singlets (Tables 2 and S2 ).
1-O-Glucuronides ( MII-5 a nd -8). The p resence of 1-O-GlcUA i n MII-8 (lastourvilline 1-O-β-D-glucuronide) was e lucidated ba sed on t he H MBC s pectrum
This article has not been copyedited and formatted. The final version may differ from this version. Table 2 ). The N OESY s pectrum showing the correlation of H-3/H-4, H-8/9-OMe, and H-11/10-OMe also supported this structure assignment.
2-O-Glucuronides ( MII-4, -6~7). M II-4 (4R-hydroxylastourvilline
2-O-β-D-glucuronide) had th e same m olecular f ormula as MII-5 ( Table 4) ( Table 4 ) a nd is the structure isomer of MII-8 wi th exchanged substituents at C-1 and C-2 as supported by the similar 1 H NMR spectra with difference for the downfield shifted H-3 (+ 0.28 ppm), H-11 (+ 0.11 ppm) and GlcUA H-1 ( + 0. 27 pp m) in MII-7 relative to t he corresponding signals in MII-8 (Table S2) .
The s tructure for MII-7 was confirmed by the NOESY spectrum (Fig. S15) , showing the NOE r elationship of G lcUA H-1 ( δ 4. 93) a nd H-3 ( δ 6. 99).
MII-6
(N-demethyllastourvilline 2 -O-β-D-glucuronide) wa s th e N-demethylated an alog o f MII-7 as evidenced b y t he MS data (T able 4 ), a 1 4 amu less than MII-7, a nd their similarity in 1 H NMR spectra except for lacking the NMe signal in MII-6 (Table S2) .
Di-Conjugates
This article has not been copyedited and formatted. The final version may differ from this version. These data and the NOES Y spectrum ( Fig. S 7) , showing NOE r elationship of H-8 (δ 7.19)/ 9-O-GlcUA H-1 (δ 5.04, H'), and H-11 (δ 7.99)/ 10-O-GlcUA H-1 (δ 4.95, H-1"), thus established MII-1 as O-demethylcassythicine 9,10-di-O-β-D-glucuronide. ( Fig. S 9) , showing one -bond 1 H/ 13 C shift co rrelation for G lc H -6s/ Glc C-6 [δ H 3.7 5 ( dd) and 3. 85 ( dd)/ δ C 6 2.1 ( t)], further supported MII-2 to c ontain the Glc moiety. The NOESY spectrum (Fig. S9) (Table S 3) were obt ained in directly from t he HMBC and HS QC spectral a nalyses due t o li mited amounts of materials. The physical da ta of t hese m etabolites, in cluding UV, s pecific rotation (isolated ones), CD and MS (MI-1~9) were listed as supplemental data.
10-O-Glucosyl-9-O-glucuronide M II-2. MII-2 ha d t he molecular f ormula
The HPLC-DAD analysis of Fr.C, obtained from feces, showed no detectable peak having U V a bsorption si milar to di centrine. F urthermore, a ttempts t o sc reen the potential sulfate conjugates based on the MS data were made via HPLC-DAD-MS, but none of them were detected in both urine and feces samples. 
